GLP-1 (glucagon-like peptide-1) shots are a type of injectable medication used to treat type 2 diabetes
Brain Res 2009
During a median follow-up of 5.4 (IQR 5.15.9) years, patients with a 1.5 mg/week subcutaneous injection of dulaglutide showed a lower incidence rate of the primary composite outcome including non-fatal myocardial infarction, non-fatal stroke, or death from cardiovascular causes ( HR = 0.88, 95% CI 0.790.99, P = 0.026) [62]
They tell the body to upregulate processes it already knows how to do, such as repair, regeneration, or metabolic regulation, explains Amanda Kahn, MD, a board-certified internist in New York City
A 2024 systematic review confirmed neuroprotective effects across multiple preclinical rodent and cell-line models, including reduced amyloid-beta accumulation, protection of dopaminergic neurons, and improved cognitive function in Alzheimers and Parkinsons disease models
It may be particularly beneficial for individuals who struggle to achieve adequate blood sugar control with existing therapies or who are at high risk of cardiovascular events
